Gene expression of the molecules in PI3K pathway was elevated in cetuximab-resistant strains compared to cetuximab-susceptible cells [43], and addition of mTOR/PI3K inhibitor effectively achieved control of cell growth in HNSCC that acquired resistance to EGFR inhibitors [44, 45]. This evidence concerns the gene PIK3CG and head and neck squamous cell carcinoma.